Top-News

Generex Biotechnology News

Keine aktuellen Kursdaten verfügbar
WKN: 922012
ISIN: US3714851033
Typ: Aktie

Generex Biotechnology News

29.04.19 - PR Newswire
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic ...
01.02.19 - PR Newswire
KALY - Kali-Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report Preview
KALY - Kali-​Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report Preview PR Newswire
28.11.18 - PR Newswire
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc. Announces Commercial Launch of FDA Approved Excellagen®, Proprietary, ...
27.11.18 - PR Newswire
Generex Biotechnology Signs Clinical Trial Agreement With the NSABP Foundation, Inc. for Phase II Clinical Trial of AE37 in Combination With Pembrolizumab (Keytruda®) for Treatment of Triple-Negative Breast Cancer
Generex Biotechnology Signs Clinical Trial Agreement With the NSABP Foundation, Inc. for Phase II Clinical Trial of AE37 in Combination With Pembrolizumab (Keytruda®) for ...
25.01.17 - PR Newswire
Yutaka Niihara, MD, MPH, CEO of Emmaus, Appointed Executive Chairman of Generex Biotechnology Corporation
Yutaka Niihara, MD, MPH, CEO of Emmaus, Appointed Executive Chairman of Generex Biotechnology Corporation PR Newswire
24.01.17 - PR Newswire
Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex Biotechnology Corporation
Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex Biotechnology Corporation PR Newswire
15.10.15 - PR Newswire
Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine
Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine PR Newswire
13.10.15 - PR Newswire
Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd.
Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. GNBT pursuing vend-in strategy to enhance stockholder value PR Newswire
06.10.15 - PR Newswire
Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd.
Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. PR Newswire
01.10.15 - PR Newswire
Generex Announces Issuance of Buccal Cannabis White Paper
Generex Announces Issuance of Buccal Cannabis White Paper PR Newswire
08.09.15 - PR Newswire
Generex Announces Commencement of Buccal Leuprolide R&D Work
Generex Announces Commencement of Buccal Leuprolide R&D Work PR Newswire
27.08.15 - PR Newswire
Generex Announces Issuance of Buccal Insulin White Paper
Generex Announces Issuance of Buccal Insulin White Paper PR Newswire
25.08.15 - PR Newswire
Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project
Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project PR Newswire
06.08.14 - PR Newswire
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the ...
12.06.14 - PR Newswire
Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial
Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial PR Newswire
10.06.14 - PR Newswire
Generex / Antigen Express to Participate in 2014 BIO International Convention
Generex / Antigen Express to Participate in 2014 BIO International Convention PR Newswire
20.05.14 - PR Newswire
Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO
Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO PR Newswire
30.04.14 - PR Newswire
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting PR Newswire
27.03.14 - PR Newswire
Generex Announces $2,075,000 Capital Investment
Generex Announces $2,075,000 Capital Investment Funds will be applied to clinical & regulatory programs, including buccal insulin PR Newswire
26.03.14 - PR Newswire
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium PR Newswire

Newssuche

Videos

newspaper
08:50 Uhr
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »